fda removes semaglutide from shortage list Hims & Hers stock falls 25% as curtails compounded GLP-1s fda remove semaglutide from shortage

Semaglutide is a GLP-1 receptor agonist that reduces appetite

Ozempic, which contains the active ingredient semaglutide, is licensed for the treatment of diabetes in the UK (although was previously prescribed off-label for weight loss), while Wegovy is used for weight management

In particular, they are popular among overweight people seeking alternatives to bariatric surgery

Neurological and Psychological Effects: Some users have reported severe depression or suicidal thoughts, prompting investigations into whether the drugs impact on brain pathways could extend to mental health

Enhanced fertility : Regular ovulation means better chances at conception for those trying to get pregnant

Insert air into the vial Remove the cap from the vial: If the vial is multidose, note when it was first opened